A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

November 14, 2017

Primary Completion Date

December 18, 2017

Study Completion Date

March 30, 2018

Conditions
Healthy
Interventions
DRUG

Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15% + mucus adhesive polymer

Test product will be applied twice a day (b.i.d) every 12 h once in the morning and once in the evening for 6 consecutive days (from Day 1 to Day 6) and once in the morning on Day 7 for a total of 13 dose

DRUG

Cetylpyridinium Chloride 0.05% + Benzydamine HCl 0.15%

Reference Product will be applied twice a day (b.i.d) every 12 h once in the morning and once in the evening for 6 consecutive days (from Day 1 to Day 6) and once in the morning on Day 7 for a total of 13 dose

Trial Locations (1)

CH-6864

CROSS Research S.A., Phase I Unit, Via F.A. Giorgioli 14 Phone: Fax: +41.91.63.00.511 Email:, Arzo

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cross Research S.A.

INDUSTRY

lead

Aziende Chimiche Riunite Angelini Francesco S.p.A

INDUSTRY

NCT03706781 - A Novel Mouthwash Formulation CTP/BNZ With Mucus Adhesive Polymer | Biotech Hunter | Biotech Hunter